Tislelizumab Approved for First-Line in ESCC ...Middle East

Medscape - News
Tislelizumab Approved for First-Line in ESCC
The Chinese immune checkpoint inhibitor has picked up its third indication within a year. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Tislelizumab Approved for First-Line in ESCC )

Also on site :



Latest News